GlaxoSmithKline (GSK) is built from a rich legacy of science, medicine and business success consisting of the companies Wellcome Inc, Glaxo, SmithKline and French and Beecham Limited. GSK entails Nobel prize-winning research, medical breakthroughs and a portfolio of products that covers hundreds of medically critical medications. These, combined with strong business skills give GSK an estimated seven percent market share of the pharmaceutical industry worldwide today.
With our headquarters in the United Kingdom, GSK employs over 100,000 people in over 80 countries. Patients today are doing more, feeling better and living longer - benefiting from many medical advances which include pharmaceutical research. GSK leads in four key therapeutic areas- anti-infectives, central nervous system (CNS), respiratory and gastro-intestinal/metabolic. In addition we are leaders in the relatively overlooked area of vaccines and we also have a growing oncology portfolio.
We also have a consumer healthcare portfolio comprising over-the-counter (OTC) medicines, oral care products, and nutritional healthcare drinks, all of which are amongst the market leaders.
Why we are who we are today is because we believe in what we do- and we do it with integrity and dedication. We believe GSK has the most productive pipeline in the industry as well as the most extensive portfolio of R&D projects and marketed products for diseases of the developing world. We are the only company undertaking R&D for the prevention and treatment of all three third world priority diseases, as set by the World Health Organization (WHO), namely; HIV/AIDS, Tuberculosis (TB) and Malaria. Since we operate in an increasingly global environment where we can reap economies of scale, we leverage this scale by building interdependent businesses that share successful practices across business boundaries and geographic borders. GSK continues to demonstrate its commitment to corporate responsibility by helping to improve access to better medicines in the developing world.
Our single greatest source of competitive advantage- our people, no matter what part of the world they are in, are offered a work environment that supports an informed, empowered and resilient workforce. These people are valued highly by GSK who thrives on their diverse knowledge, perspectives, experience and styles.
Of the 100,000 employees worldwide, over 40,000 are in sales and marketing, the largest sales force in the entire industry. Around 35,000 employees work at 80 manufacturing sites in 37 countries and over 15,000 are in R&D. GSK R&D is based at 24 sites in 11 countries, giving us a leading position in genomics/genetics and new drug discovery technologies.
